Skip to main content
Fig. 1 | Cardio-Oncology

Fig. 1

From: Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development

Fig. 1

Median systolic blood pressure before and after pazopanib initiation in patients meeting criteria for pazopanib-induced hypertension (N = 20). Baseline median SBP is at the far left and is equal to 128.6 mmHg. Median maximal SBP is within the middle box and is equal to 167.5 mmHg. Median time to reach maximal SBP was 24.5 days as described in Table 3. Overall median SBP during pazopanib treatment is within the box on the far right and is equal to 136.8 mmHg. Solid line within each box represents the median. Boxes represent the interquartile range. Bars represent the range. SBP: systolic blood pressure

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us